FineTech Pharmaceutical
Developing Active Pharmaceutical Ingredients
Company Overview
Snapshot
Founded in January 1990 by Dr. Arie Gutman, FineTech Pharmaceutical operates with 11–50 employees. The company was acquired by OPKO Health in December 2011, marking a significant exit in the pharmaceutical sector.
Business overview
FineTech Pharmaceutical specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), focusing on bypassing process and polymorph patents. The company provides analytical method development and patent analysis services to accelerate client product market entry. Its product portfolio includes Cabergoline, Latanoprost, Travoprost, Bimatoprost, Nabilone, donepezil hydrochloride, aminolevulinic acid hydrochloride, melatonin, and methylbenzethonium chloride. FineTech operates across six facilities, adhering to cGMP standards and FDA registration, serving the Health Tech & Life Sciences sector.
Strategic signal
The acquisition of FineTech Pharmaceutical by OPKO Health in December 2011 for $27.5 million signaled a strategic consolidation within the pharmaceutical industry. This event highlighted the value placed on specialized API development capabilities and patent navigation expertise, indicating a market trend towards integrating innovative drug development assets into larger corporate structures.
Company Intelligence Q&A
- What is FineTech Pharmaceutical's primary focus?
- FineTech Pharmaceutical primarily focuses on developing and manufacturing Active Pharmaceutical Ingredients (APIs) and providing services like analytical method development and patent analysis to facilitate faster market entry for client products.
- When was FineTech Pharmaceutical founded?
- FineTech Pharmaceutical was founded in January 1990.
- Who founded FineTech Pharmaceutical?
- FineTech Pharmaceutical was founded by Dr. Arie Gutman.
- Which company acquired FineTech Pharmaceutical?
- FineTech Pharmaceutical was acquired by OPKO Health in December 2011.
- What types of products does FineTech Pharmaceutical develop?
- FineTech Pharmaceutical develops various APIs, including Cabergoline, Latanoprost, Travoprost, Bimatoprost, Nabilone, donepezil hydrochloride, aminolevulinic acid hydrochloride, melatonin, and methylbenzethonium chloride.